293 results on '"Burke TA"'
Search Results
2. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-flammatory drugs
3. Do recent data from the Seychelles Islands alter the conclusions of the NRC report on the toxicological effects of methylmercury?
4. Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting
5. PCV52 LOSARTAN-BASED VERSUS ATENOLOL-BASED THERAPY IN PATIENTS WITH HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY: AN ECONOMIC EVALUATION OF THE LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION IN HYPERTENSION (LIFE) STUDY FOR GERMANY
6. PCV59 LIPID TESTING AMONG PATIENTS RECEIVING FIRST-EVER STATIN THERAPY IN UK GENERAL PRACTICES
7. PST2 COST-EFFECTIVENESS OF LOSARTAN IN PATIENTS WITH HYPERTENSION AND LVH: AN ECONOMIC EVALUATION FOR THE NETHERLANDS BASED ON THE LIFE-STUDY
8. PCVI5 COST-EFFECTIVENESS OF LOSARTAN IN PATIENTS WITH HYPERTENSION AND LVH IN SPAIN: AN ECONOMIC EVALUATION BASED ON THE LIFE TRIAL
9. OP0138 Relative gastrointestinal toxicity of cox-2 specific and traditional nsaids in a high-risk population from a health maintenance organisation
10. SAT0097 Success in osteoarthritis (oa) trial: celecoxib significantly reduces the risk of upper gastrointestinal (ugi) hospitalizations compared to diclofenac and naproxen in 13,274 randomised patients with oa
11. PG17: RATE OF GI DISTRESS AMONG PATIENTS TREATED WITH CELECOXIB, PLACEBO, OR NSAIDs USING THREE DIFFERENT STATISTICAL METHODS
12. PAD8: INTERPRETATION OF HAQ DISABILITY INDEX IMPROVEMENT AMONG RHEUMATOID ARTHRITIS (RA) PATIENTS IN RANDOMIZED CLINICAL TRIALS
13. TPCT6: INCREASED UPPER GASTROINTESTINAL (UGI) DISTRESS AMONG ARTHRITIS PATIENTS TREATED WITH NSAIDS AS COMPARED TO CELECOXIB AND PLACEBO
14. PAD4: CLINICALLY MEANINGFUL IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) AMONG OSTEOARTHRITIS (OA) PATIENTS
15. PAD3: RESPONSIVENESS OF WOMAC IMPROVEMENT TO PATIENTS' AND PHYSICIANS' GLOBAL ASSESSMENT (PtGA & PhGA) OF IMPROVEMENT AMONG OSTEOARTHRITIS PATIENTS (OA)
16. Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting.
17. An examination of environmental public health organizational and workforce configurations in the Northeast/Mid-Atlantic United States: how do we determine if these configurations impact performance?
18. Disaster-related injuries in the period of recovery: the effect of prolonged displacement on risk of injury in older adults.
19. Meeting local needs while developing public health practice skills: a model community-academic partnership.
20. Effective environmental public health surveillance programs: a framework for identifying and evaluating data resources and indicators.
21. Dosage, titration, and gaps in treatment with extended release niacin in clinical practice.
22. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.
23. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
24. Population impact of losartan use on stroke in the European Union (EU): Projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
25. A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
26. Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension.
27. A comparison of time-and-motion and self-reporting methods of work measurement.
28. An examination of the educational needs for environmental health and protection.
29. Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.
30. Protecting and promoting the nation's health: the environmental public health workforce as a critical component.
31. Manufactured Chemicals and Children's Health - The Need for New Law.
32. Barriers to Youth Disclosing Self-Injurious Thoughts and Behaviors: A Focus on the Therapeutic Context.
33. Application and demonstration of meso-activity exposure factors to advance estimates of incidental soil ingestion among agricultural workers.
34. Disclosures of self-injurious thoughts and behaviors to parents in the context of adolescent therapy: A qualitative investigation.
35. Nonsuicidal Self-Injury in Preadolescents.
36. Nonsuicidal self-injury characteristics: A mixed methods analysis of differences between veterans and civilians.
37. Characterizing Adolescent Disclosures of Suicidal Thoughts and Behavior to Parents.
38. Mental imagery of suicide and non-suicidal self-injury: A meta-analysis and systematic review.
39. Evaluation of variant calling algorithms for wastewater-based epidemiology using mixed populations of SARS-CoV-2 variants in synthetic and wastewater samples.
40. Effects of Social Media Use on Connectivity and Emotions During Pandemic-Induced School Closures: Qualitative Interview Study Among Adolescents.
41. A qualitative characterization of meso-activity factors to estimate soil exposure for agricultural workers.
42. COVID-19-Specific Suicidal Thoughts and Behaviors in Psychiatrically Hospitalized Adolescents.
43. Reactions to naturalistic smartphone deprivation among psychiatrically hospitalized adolescents.
44. Urban Soil Safety Policies: The Next Frontier for Mitigating Lead Exposures and Promoting Sustainable Food Production.
45. Digital media-related precursors to psychiatric hospitalization among youth.
46. Early-life conditions impact juvenile telomere length, but do not predict later life-history strategies or fitness in a wild vertebrate.
47. Sleep irregularity and nonsuicidal self-injurious urges and behaviors.
48. Exploring Adolescent Experiences with Disclosing Self-Injurious Thoughts and Behaviors Across Settings.
49. Key considerations for assessing soil ingestion exposures among agricultural workers.
50. Charting a Path Forward: Assessing the Science of Chemical Risk Evaluations under the Toxic Substances Control Act in the Context of Recent National Academies Recommendations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.